Intensity Therapeutics is a Qualified Connecticut Business
Intensity Therapeutics' is a "Qualified Connecticut Business" (QCB) as approved by CT Innovations. The State of Connecticut launched a program in 2010 that allows Angels providing capital to QCBs to take a credit against Connecticut State income tax for certain investments made in qualifying businesses. Investments must be at least $25,000 in order to be considered under the Program and the income tax credit equals 25% of the cash investment up to a maximum credit of $250,000.
Intensity Therapeutics is a development stage company that has conducted proof-of-concept in vivo experiments using its novel in situ vaccination technology. The Company is interested in collaborating with pharmaceutical, imaging or biotechnology companies interested in developing the new approach to treating cancer.
Who we are
Intensity Therapeutics is a product development stage company. We are seeking partnerships/investors interested in advancing the company’s anti-cancer platform technology and lead product INT230-6.